Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epithelial cell transforming sequence 2 oncogene pseudogene (ENSG00000271701) is a genomic locus annotated as a pseudogene based on its high sequence similarity to the ECT2 (epithelial cell transforming sequence 2) oncogene, which encodes a guanine nucleotide exchange factor implicated in cell cycle regulation and oncogenesis. However, this particular locus contains disabling mutations or lacks necessary regulatory elements and thus does not produce a functional protein product. Pseudogenes such as this may occasionally be transcribed or serve as regulators of their parent gene through RNA-mediated mechanisms, but there is no evidence that ENSG00000271701 acts as a receptor, enzyme, transporter, or therapeutic target. This designation is commonly regarded as "incorrect" in the context of drug targeting, since it refers to a non-functional pseudogene rather than an active molecule or receptor relevant for therapeutic or diagnostic intervention[1][5].
None; pseudogenes do not produce active molecules subject to drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epithelial cell transforming sequence 2 oncogene pseudogene (null).